Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Fulgent Genetics Inc (FLGT)

Fulgent Genetics Inc (FLGT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,615,216
  • Shares Outstanding, K 30,327
  • Annual Sales, $ 992,580 K
  • Annual Income, $ 507,360 K
  • 60-Month Beta 1.47
  • Price/Sales 1.60
  • Price/Cash Flow 2.97
  • Price/Book 1.21
Trade FLGT with:

Options Overview Details

View History
  • Implied Volatility 54.28% ( -0.31%)
  • Historical Volatility 55.54%
  • IV Percentile 1%
  • IV Rank 3.67%
  • IV High 101.13% on 11/08/21
  • IV Low 52.49% on 08/12/22
  • Put/Call Vol Ratio 0.12
  • Today's Volume 707
  • Volume Avg (30-Day) 810
  • Put/Call OI Ratio 0.44
  • Today's Open Interest 14,935
  • Open Int (30-Day) 14,782

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate 0.18
  • Number of Estimates 1
  • High Estimate 0.18
  • Low Estimate 0.18
  • Prior Year 3.93
  • Growth Rate Est. (year over year) -95.42%

Price Performance

See More
Period Period Low Period High Performance
1-Month
50.01 +0.50%
on 08/09/22
65.17 -22.88%
on 08/04/22
-8.13 (-13.92%)
since 07/15/22
3-Month
47.34 +6.17%
on 06/13/22
65.17 -22.88%
on 08/04/22
-3.37 (-6.28%)
since 05/16/22
52-Week
47.34 +6.17%
on 06/13/22
109.55 -54.12%
on 12/20/21
-45.77 (-47.66%)
since 08/16/21

Most Recent Stories

More News
Kirby McInerney LLP Announces an Investigation of Shareholder Claims Against Fulgent Genetics, Inc. (FLGT)

The law firm of Kirby McInerney LLP is investigating potential claims against Fulgent Genetics, Inc. (“Fulgent” or the “Company”) (NASDAQ: FLGT ). The investigation concerns whether Fulgent...

FLGT : 50.26 (-5.63%)
FULGENT ALERT: Bragar Eagel & Squire, P.C. is Investigating Fulgent Genetics, Inc. on Behalf of Fulgent Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Fulgent Genetics, Inc. (“Fulgent” or the “Company”) (NASDAQ: FLGT) on...

FLGT : 50.26 (-5.63%)
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Fulgent Genetics, Inc. (FLGT) on Behalf of Investors

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Fulgent Genetics, Inc. (“Fulgent” or the...

FLGT : 50.26 (-5.63%)
INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in Fulgent Genetics, Inc. with Losses of $100,000 to Contact the Firm

The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Fulgent Genetics, Inc. (“Fulgent” or “the Company”) (NASDAQ:...

FLGT : 50.26 (-5.63%)
FULGENT ALERT: Bragar Eagel & Squire, P.C. is Investigating Fulgent Genetics, Inc. on Behalf of Fulgent Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Fulgent Genetics, Inc. (“Fulgent” or the “Company”) (NASDAQ: FLGT) on...

FLGT : 50.26 (-5.63%)
Fulgent Genetics, Inc. (FLGT) Q2 2022 Earnings Call Transcript

FLGT earnings call for the period ending June 30, 2022.

FLGT : 50.26 (-5.63%)
INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Fulgent Genetics, Inc. with Losses of $100,000 to Contact the Firm

The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Fulgent Genetics, Inc. (“Fulgent” or “the Company”) (NASDAQ:...

FLGT : 50.26 (-5.63%)
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Fulgent Genetics, Inc. (FLGT) on Behalf of Investors

Law Offices of Howard G. Smith announces an investigation on behalf of Fulgent Genetics, Inc. (“Fulgent” or the “Company”) (NASDAQ: FLGT ) investors concerning the Company’s possible violations...

FLGT : 50.26 (-5.63%)
The Law Offices of Frank R. Cruz Announces Investigation of Fulgent Genetics, Inc. (FLGT) on Behalf of Investors

The Law Offices of Frank R. Cruz announces an investigation of Fulgent Genetics, Inc. (“Fulgent” or the “Company”) (NASDAQ: FLGT ) on behalf of investors concerning the Company’s possible violations...

FLGT : 50.26 (-5.63%)
Why I Bought More of This Under-the-Radar Stock

This healthcare business has tailwinds behind it.

FLGT : 50.26 (-5.63%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Fulgent Genetics, Inc. provides genetic testing services to physicians with clinically actionable diagnostic information. The company's technology platform integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory process...

See More

Key Turning Points

3rd Resistance Point 55.22
2nd Resistance Point 54.16
1st Resistance Point 52.21
Last Price 50.26
1st Support Level 49.20
2nd Support Level 48.14
3rd Support Level 46.19

See More

52-Week High 109.55
Fibonacci 61.8% 85.79
Fibonacci 50% 78.44
Fibonacci 38.2% 71.10
Last Price 50.26
52-Week Low 47.34

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar